Search results
Results from the WOW.Com Content Network
Preoperative PVE is a very well tolerated procedure with extremely low mortality rates (0.1 percent) and technical failure rates (0.4 percent). [3] Complication rates from the procedure are low as well (2–3 percent) and include portal vein thrombosis, liver infarction, necrosis, infection, pneumothorax, and other risks as listed above. [3]
1990 – Radiofrequency ablation (RFA) technique for liver tumors. 1990s – Treatment of bone and kidney tumors by embolization. 1990s – RFA for soft tissue tumors, i.e., bone, breast, kidney, lung and liver cancer. 1997 – Intra-arterial delivery of tumor-killing viruses and gene therapy vectors to the liver.
What links here; Upload file; Special pages; Printable version; Page information
Radiation therapy is used to kill cancer cells; however, normal cells are also damaged in the process. Currently, therapeutic doses of radiation can be targeted to tumors with great accuracy using linear accelerators in radiation oncology; however, when irradiating using external beam radiotherapy, the beam will always need to travel through healthy tissue, and the normal liver tissue is very ...
Transcatheter arterial chemoembolization (TACE) is a minimally invasive procedure performed in interventional radiology to restrict a tumor's blood supply. Small embolic particles coated with chemotherapeutic drugs are injected selectively through a catheter into an artery directly supplying the tumor.
Kate Middleton announced today she is finished with her chemotherapy treatment and cancer free, sharing the news in a three minute long video (watch above) filmed in Norfolk last month.
The most common malignant neoplasms (cancers) of the liver are metastases; those arising from colorectal cancer are among the most common, and the most amenable to surgical resection. The most common primary malignant tumour of the liver is the hepatocellular carcinoma. Another primary malignant liver tumor is the cholangiocarcinoma.
In particular, this therapy has grown in use for patients with hepatocellular carcinoma, since many patients present with advanced disease or compromised liver function. Clinical applications of MWA have also included treatment of renal, adrenal, and bone malignancies. The goals of ablation of thoracic malignancies include: 1.